Evidence map›Paper›PMID 41845119›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Gender disparities in the global burden of nasopharyngeal carcinoma: persistence and evolution of male predominance.

Wangyan Zhong, Yibing Xu, Hang Yuan, Yali Meng

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wangyan ZhongDepartment of Radiation Oncology, Shaoxing People's Hospital, The First Hospital of Shaoxing University, Shaoxing, 312000, Zhejiang, China.
Yibing XuDepartment of Radiation Oncology, Shaoxing People's Hospital, The First Hospital of Shaoxing University, Shaoxing, 312000, Zhejiang, China.
Hang YuanDepartment of Radiation Oncology, Shaoxing People's Hospital, The First Hospital of Shaoxing University, Shaoxing, 312000, Zhejiang, China.
Yali MengDepartment of Oncology, Shaoxing People' s Hospital, The First Hospital of Shaoxing University, No.568 Zhongxing North Road, Shaoxing, 312000, Zhejiang, China. 451511176@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesNasopharyngeal carcinoma (NPC) is a malignant tumor that poses a considerable challenge to global health. This study aimed to evaluate the trends in incidence, mortality, prevalence, and disability-adjusted life years (DALYs) associated with NPC from 1990 to 2021, utilizing data from the Global Burden of Disease (GBD) study, while also examining the relationships between these trends and socioeconomic development as well as gender disparities. MATERIALS AND

methodsThe data were obtained from the GBD 2021 study, and trends were analyzed using Joinpoint regression to determine the average annual percentage change (AAPC). Future trends were forecasted using the ARIMA model.

resultsThe findings revealed that the global number of new NPC cases increased from 76,255.8 in 1990 to 118,877.9 in 2021. East Asia bore the highest burden in 2021, with 68,038.9 new cases (57.2% of the global total) and 352,017.7 prevalent cases (62.1% of the global total). Notably, East Asia also achieved the most substantial reductions in mortality rates, with an AAPC of -3.7 (95% CI, -4.17 to -3.24) and DALYs rates with an AAPC of -3.75 (95% CI, -4.21 to -3.29). Although the global age-standardized incidence (ASIR), mortality (ASMR), and DALY rates (ASDR) declined from 1990 to 2021, the disease burden remained substantial and was substantially higher in males than in females, with a significant increase in the age-standardized prevalence rate (ASPR) among males. Prediction models indicated that the incidence and prevalence among males were expected to continue rising from 2022 to 2036, suggesting that the future burden of NPC will primarily impact males. A significant portion of the NPC burden is associated with risk factors such as alcohol consumption, smoking, and occupational exposure to formaldehyde, with variations observed by gender and age. Unlike females, for whom alcohol use was the supreme risk factor, the most important risk factor for males changed from alcohol use to smoking after age 60. Between 1990 and 2020, age-standardized rates attributable to smoking and alcohol declined significantly for both genders, although the decline was more pronounced in females, with improvements in males slowing after 2010.

conclusionsThese findings provide a scientific foundation for public health policy-making regarding NPC, highlighting the necessity for targeted public health interventions that consider gender disparities to further mitigate the impact of NPC.

Indexed as

Global Burden of DiseaseNasopharyngeal CarcinomaNasopharyngeal NeoplasmsAdolescentAdultAgedDisability-Adjusted Life YearsFemaleGlobal HealthHumansIncidenceMaleMiddle AgedPrevalenceQuality-Adjusted Life YearsSex DistributionEpidemiologyGender disparitiesGlobal burdenNasopharyngeal CarcinomaRisk factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.